According to Janux Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$1.52 a decrease over its 2021 EPS that were of -$1.27.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.63 | 7.24% |
2022 | -$1.52 | 19.95% |
2021 | -$1.27 | 132.99% |
2020 | -$0.54 |